Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

23.02
-0.4600-1.96%
Post-market: 19.37-3.6500-15.86%19:59 EST
Volume:46.35M
Turnover:1.04B
Market Cap:5.24B
PE:42.88
High:23.62
Open:22.30
Low:21.12
Close:23.48
52wk High:72.98
52wk Low:21.12
Shares:227.65M
Float Shares:197.51M
Volume Ratio:1.45
T/O Rate:23.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5369
EPS(LYR):0.5322
ROE:26.21%
ROA:5.54%
PB:9.02
PE(LYR):43.25

Loading ...

REFILE-For many, this year's Super Bowl features a salad - and food companies are racing to react

Reuters
·
Yesterday

REUTERS NEWS SCHEDULE AT 10 p.m. GMT/6 a.m. SGT

Reuters
·
Yesterday

Hims & Hers to Stop Offering Wegovy Copycat Drug After Regulatory Scrutiny -- Barrons.com

Dow Jones
·
Yesterday

BRIEF-Hims & Hers Health Inc Says We Have Decided To Stop Offering Access To Compounded Semaglutide Pill

Reuters
·
Yesterday

Hims & Hers Health Inc: We Have Decided to Stop Offering Access to This Treatment

THOMSON REUTERS
·
Yesterday

Hims & Hers Health Inc: Since Launching Compounded Semaglutide Pill on Our Platform, Had Constructive Conversations With Stakeholders Across Industry

THOMSON REUTERS
·
Yesterday

CORRECTED-Weight-loss drugs to compete on biggest stage with Super Bowl ads

Reuters
·
Feb 07

Health Regulators Ask DOJ to Investigate Hims & Hers. The Stock Plunges. -- Barrons.com

Dow Jones
·
Feb 07

US Signals Crackdown on Compounded Weight-Loss Drugs; Hims Shares Tumble 14%, Novo-Nordisk up 4%, Eli Lilly up 1%

Reuters
·
Feb 07

BRIEF-Hims & Hers Health Says Co Looks Forward To Continuing To Engage With FDA To Ensure Safe Access To Affordable Healthcare

Reuters
·
Feb 07

Hims & Hers Is Offering a New Cancer Test. It May Not Be Ready for Prime Time. -- Barrons.com

Dow Jones
·
Feb 07

Hims & Hers Health Inc: Look Forward to Continuing to Engage With US FDA to Ensure Safe Access to Affordable Healthcare

THOMSON REUTERS
·
Feb 07

Hims & Hers Health: Always Operated With Deep Commitment to Safety and Best Interests of Consumers and in Compliance With Applicable Law

THOMSON REUTERS
·
Feb 07

FDA to restrict GLP‑1 ingredients used in non‑approved compounded drugs

Reuters
·
Feb 07

BRIEF-HHS General Counsel Mike Stuart Says Based On Review Of Applicable Facts, Referred Hims To DOJ For Investigation For Potential Violations

Reuters
·
Feb 07

HHS General Counsel refers Hims to US Justice Department for investigation

Reuters
·
Feb 07

FDA: Taking Steps to Combat Misleading Direct-to-Consumer Advertising & Marketing

THOMSON REUTERS
·
Feb 07

Hhs General Counsel Mike Stuart: Based on Review of Applicable Facts, Referred Hims to DOJ for Investigation for Potential Violations

THOMSON REUTERS
·
Feb 07

FDA Vows Swift Action Against Unapproved Drugs, Derailing HIMS' Weight-Loss Copycat Plan; Shares Drop Nearly 6%

Deep News
·
Feb 07

Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill

Dow Jones
·
Feb 07